Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eisai's kidney drug wins expanded indication in the U.S.
Eisai's kidney drug wins expanded indication in the U.S.
Eisai's kidney drug wins expanded indication in the U.S.
Submitted by
admin
on May 17, 2016 - 9:35am
Source:
BioPharma Dive
News Tags:
Eisai
advanced renal cell carcinoma
kidney cancer
Lenvima
RCC
Headline:
Eisai's kidney drug wins expanded indication in the U.S.
Do Not Allow Advertisers to Use My Personal information
